3-AMINO-2-BROMO-5-CHLOROPYRIDINE
CAS90902-83-3
3-AMINO-2-BROMO-5-CHLOROPYRIDINE (CAS 90902-83-3, C5H4BrClN2) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 90902-83-3
- Formula
- C5H4BrClN2
- Mol. weight
- 207.45 g/mol
Chemical Specifications
Identifiers
| CAS number | 90902-83-3 |
|---|---|
| Product name | 3-AMINO-2-BROMO-5-CHLOROPYRIDINE |
| Synonyms | 3-AMINO-2-BROMO-5-CHLOROPYRIDINE |
| Molecular formula | C5H4BrClN2 |
| Molecular weight | 207.45 g/mol |
| InChI | InChI=1/C5H4BrClN2/c6-5-4(8)1-3(7)2-9-5/h1-2H,8H2 |
Physical and chemical properties
| Melting Point | 141-143 ( ℃ ) |
|---|---|
| Boiling Point | 142.9 ( ℃ ) |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of 3-AMINO-2-BROMO-5-CHLOROPYRIDINE?
The CAS Registry Number of 3-AMINO-2-BROMO-5-CHLOROPYRIDINE is 90902-83-3. 3-AMINO-2-BROMO-5-CHLOROPYRIDINE is also known as 3-AMINO-2-BROMO-5-CHLOROPYRIDINE.
What is the molecular formula and molecular weight of 3-AMINO-2-BROMO-5-CHLOROPYRIDINE?
The molecular formula of 3-AMINO-2-BROMO-5-CHLOROPYRIDINE is C5H4BrClN2, and its molecular weight is 207.45 g/mol.
How can I request a quotation for 3-AMINO-2-BROMO-5-CHLOROPYRIDINE?
Send an inquiry for 3-AMINO-2-BROMO-5-CHLOROPYRIDINE (CAS 90902-83-3) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for 3-AMINO-2-BROMO-5-CHLOROPYRIDINE
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.